Suppr超能文献

高血压急症和亚急症的管理

Management of hypertensive urgencies and emergencies.

作者信息

Abdelwahab W, Frishman W, Landau A

机构信息

Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

J Clin Pharmacol. 1995 Aug;35(8):747-62. doi: 10.1002/j.1552-4604.1995.tb04116.x.

Abstract

Hypertensive emergency is a condition in which there is elevation of both systolic and diastolic blood pressure with the presence of acute target organ disease. Hypertensive urgency is a condition where the blood pressure is elevated (diastolic > 120 mmHg) with the absence of acute target organ disease. Hypertensive emergencies are best managed with parenteral drugs and careful intraarterial blood pressure monitoring. Hydralazine has been widely used in treatment of hypertension in eclampsia and preeclampsia, and its safety has been demonstrated in these patients. Sodium nitroprusside (SNP) has the most reliable antihypertensive activity, which begins immediately after its administration and ends when the infusion is stopped. As with diazoxide, it should be used with caution in patients with impaired cerebral flow. SNP is the preferred drug in obtaining controlled hypotension in patients undergoing neurovascular surgery. Intravenous nitroglycerin is useful in patients prone to myocardial ischemia, but should be avoided in patients with increased intracranial pressure. Esmolol is effective in controlling both supraventricular tachyarrhythmias and severe hypertension. Its short onset of duration of action make it useful in the emergent setting, but because of its negative inotropic effect its use should be avoided in patients with low cardiac output. Verapamil should not be used in patients with preexisting conduction abnormalities. Nicardipine is a potent arteriolar vasodilator without a significant direct depressant effect on myocardium. As with other afterload reducing agents, it should not be used in patients with severe aortic stenosis. Because angiotensin-converting enzyme (ACE) inhibitors generally cause cerebral vasodilatation, enalaprilat may be particularly beneficial for patients who are at high risk of developing cerebral hypotensive episodes secondary to impaired cerebral circulation. Fenoldopam, a selective post-synaptic dopaminergic receptor (DA1) has been shown to be effective in treating severe hypertension with a lower incidence of side effects than SNP. Hypertensive urgencies can usually be managed with oral agents. Oral nifedipine, captopril, clonidine, labetalol, prazosin, and nimodipine have all been shown to be effective in these situations.

摘要

高血压急症是指收缩压和舒张压均升高且伴有急性靶器官损害的情况。高血压亚急症是指血压升高(舒张压>120mmHg)但无急性靶器官损害的情况。高血压急症最好采用胃肠外给药并进行仔细的动脉内血压监测来处理。肼屈嗪已广泛用于子痫和先兆子痫的高血压治疗,并且其安全性在这些患者中已得到证实。硝普钠(SNP)具有最可靠的降压活性,给药后立即起效,停药后作用消失。与二氮嗪一样,脑血流受损的患者应慎用。SNP是神经血管手术患者控制性降压的首选药物。静脉注射硝酸甘油对易发生心肌缺血的患者有用,但颅内压升高的患者应避免使用。艾司洛尔对控制室上性快速心律失常和重度高血压均有效。其作用起效时间短,使其在紧急情况下有用,但由于其负性肌力作用,心输出量低的患者应避免使用。维拉帕米不应用于已有传导异常的患者。尼卡地平是一种强效的小动脉血管扩张剂,对心肌无明显直接抑制作用。与其他降低后负荷的药物一样,严重主动脉瓣狭窄的患者不应使用。因为血管紧张素转换酶(ACE)抑制剂通常会引起脑血管扩张,依那普利拉可能对继发于脑循环受损而有发生脑低血压发作高风险的患者特别有益。非诺多泮,一种选择性突触后多巴胺能受体(DA1),已被证明在治疗重度高血压方面有效,且副作用发生率低于SNP。高血压亚急症通常可用口服药物处理。口服硝苯地平、卡托普利、可乐定、拉贝洛尔、哌唑嗪和尼莫地平在这些情况下均已证明有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验